Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit.
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics, 9115 Hague Road, as a hub for manufacturing of its continuous glucose monitoring system. A continuous glucose monitoring system is a small device worn by the patient with a sensor to monitor glucose levels.
The expansion, which officials said would include a refurbishment of existing facilities and could include future new construction, will create about 650 skilled manufacturing jobs and roughly 1,000 construction jobs. The company currently has 4,815 employees in Indianapolis.
“Indianapolis was a natural choice when we saw a location for this new investment,” said Richeal Cline, Roche’s head of diagnostics global operations. “This location has strong manufacturing capabilities and a long-standing history of producing diabetes care products for Roche. In fact, in 2024 we manufactured over 5 billion diabetes test strips for patients across the world.”
The Trump administration has pushed manufacturers to invest in domestic production through actions including a series of tariffs. The company said Monday’s announcement was “aligning with national efforts to strengthen local manufacturing.”
The move is part of Roche’s previously announced plan to invest $50 billion in pharmaceuticals and diagnostics over the next five years in the United States. Roche Diagnostics, with its North America unit based in Indianapolis, is a maker of instruments to help physicians and laboratories test for a wide range of patient conditions.
Cline said for the expansion Roche plans to partner with U.S. based suppliers for production equipment, engineering, design, support and construction.
Cline said the Indianapolis expansion will implement manufacturing for the current generation continuous glucose monitoring product was launched late last year in select European countries: “Our goal is to initiate production within three years,” she said.
The company said the investment was in response to a growing need, with more than 38 million Americans living with diabetes.
“The challenges of diabetes are pervasive, with millions of Americans living with the constant vigilance and countless daily decisions the disease requires,” Roche Diagnostics North America CEO Brad Moore said in a written statement. “By expanding our manufacturing capabilities in Indianapolis, we ensure reliable access to innovative monitoring solutions for individuals living with diabetes in the U.S. and worldwide.”
The Roche Diagnostics campus on the north side of Indianapolis houses operations that include U.S. research and development, laboratories, manufacturing, distribution and IT and administrative functions. The facility produces about 5.2 billion Accu-Chek diabetes test strips annually and serves as one of the company’s two global distribution hubs focused on serving the U.S. market and supporting distribution to 53 countries worldwide.
Moore said the City of Indianapolis provided a 10-year property tax abatement valued at about $40 million and the State of Indiana extended an incentive package worth $20 million in tax credits.
Basel, Switzerland-based Roche said in April that it had committed to $50 billion in U.S. investment over the next five years, including new and expanded manufacturing facilities in Indiana, Pennsylvania, Massachusetts and California.
Roche is not the only medical giant with recent large investments in U.S. operations.
Indianapolis-based Eli Lilly and Co. announced plans in February to add four new still-unnamed U.S. manufacturing sites in a roughly $27 billion investment expected to create 3,000 jobs.
Editor’s note: This story has been updated to correct the amount of the planned potential investment.
Please enable JavaScript to view this content.
Damn tariffs. Hate them. They never work.
+1, this is going to make some of these sofa economist economist here in Indianapolis very mad.
This actually has nothing to do with tariffs and everything to do with economic geography and world-scale product specialization. The exact opposite of tariffs.
Roche and its predecessor companies have been here for 50 years making a high value-add product. In addition, dozens of other life sciences companies have grown up here. Over that time, the metro area has strengthened its reputation as a life-sciences hub, and has built up a critical mass of the people with specialized skills necessary to manage FDA-approved products and production processes.
(Don’t know about sofa economists…I actually earned a degree in the field.)
Gosh you need to apply for a job with the federal government then maybe you can be treasury secretary and Brent b can be head of the Federal reserve since you both know so much about the economy
This comes straight from the article. The company said Monday’s announcement was “aligning with national efforts to strengthen local manufacturing.”
Well, in corporate-speak, “aligns with” means “we were going to do it anyway and we can win MAGA friends at the Statehouse by announcing it now”.
No big corporation spins up this level of investment in less than a year of study and consideration.
Gosh Chris, how about the inflation numbers from today. Guess that blows Brent B and your economic forecast out of the water. Maybe you can get a 50% refund on that economic degree.
Rhea, try to stay with the topic…I don’t remember saying anything about inflation.
Indiana has been adding pharma and medical device jobs for decades now because we’re good at those things, what economists call “comparative advantage” and what MBAs call “competitive”. A Hoosier might even call it “home court advantage”.
I didn’t see in the article, but where will they be building the new facility? At the current campus?
Yes, at current campus (Hague Rd.).
IBJ Democrats— how is this possible??!!??
What company would possibly invest in this knuckle dragging Neanderthal red State? Plus, who is going to work there? According to you, all the “young people” are going to leave?
Yes, how dare a company open a manufacturing facility in Indiana and pay good wages. Why according to Chris B, who has a degree in economics and Brent B Trump is destroying the economy.
Rhea, Indiana has been adding pharma and medical device jobs for decades now because we’re good at those things, what economists call “comparative advantage” and what MBAs call “competitive”. A Hoosier might even call it “home court advantage”. I’m all for this and it has nothing at all to do with politics.
MAGA trolls in the house today, with their general lack of understanding of business and economics on full display. LOL. Attributing this announcement from Roche, which has a long established presence in Indianapolis, as a product of the chaos sown by Trump’s economic policies is just stupid.
Bless their hearts.
Poor Marshall, doesn’t like it when good things happen to Indiana and the country, it defeats his democratic ranting and raving that the economy is crashing. As far at MAGA trolls, you AOC followers have the majority on here constantly bashing anything Trump does. Might want to invest in a Kleenex manufacturer, your going to need it.